Published 7 days ago • loading... • Updated 5 days ago

Galatea Bio Secures $25M to Develop Global Biobank and Enable Precision Health at Scale for All

Summary by Hastings Tribune

Building the world’s largest biobank with data from global populations to accelerate biomarker and drug discovery and development of next-generation diagnostics.Secured $25M in funding from F-Prime, Helios Digital Ventures, Digitalis Ventures, CEI Ventures, AME Cloud, Alexandria, Founders Collective, Stanford President’s…

7 Articles

All

Left

Center

Right

Hastings Tribune

Center

Galatea Bio Secures $25M to Develop Global Biobank and Enable Precision Health at Scale for All

7 days ago

Read Full Article

SFBW

Galatea Bio Secures $25M to Develop Global Biobank - S. Florida Business & Wealth

Galatea Bio, a leader in AI-driven genomic research and clinical genetic testing has secured $25 million in funding to drive discoveries in next-generation genetic analysis, biomarker discovery, and multi-omics disease modeling. Committed to enabling precision health at scale for all, Galatea Bio is expanding its Biobank of the Americas into the Galatea Global Biobank, a landmark initiative to sequence 10 million participants worldwide, with a f…

5 days ago

Read Full Article

portaldoriograndense.com

Galatea Bio's Bold Leap: Creating the World's Largest Biobank to Transform Global Healthcare

Galatea Bio, a Miami-based biotech firm, is pioneering precision medicine by establishing the world’s largest biobank. The company, founded in 2021, recently raised $25 million and aims to sequence genomes from 10 million diverse participants worldwide. Innovative efforts focus on closing the diversity gap in genomic research, particularly for underrepresented populations. Investments from F-Prime and Helios Digital Ventures support the creation…

6 days ago

Read Full Article

TheRecursive.com

Polish Intelliseq Lands €4.5M to Advance Genomic Data Analysis

Polish bioinformatics company Intelliseq, specializing in the automated analysis and interpretation of variations in the […] The post Polish Intelliseq Lands €4.5M to Advance Genomic Data Analysis appeared first on TheRecursive.com.

6 days ago

Read Full Article

Refresh Miami

Galatea Bio secures $25M to help transform global genomic research and precision medicine - Refresh Miami

Galatea Bio, a Miami-based biotech company focused on advancing precision medicine and genomic research, has raised $25 million to build the world’s largest biobank to accelerate drug discovery in diverse populations. The round of funding came from F-Prime, Helios Digital Ventures, Digitalis Ventures, AME Cloud, CEI Ventures, Alexandria, Founders Collective, Stanford President’s Fund, and HBM Genomics. The company, founded in 2021, is expanding …

6 days ago

Read Full Article

FinSMEs

Galatea Bio Raises $25M in Funding

Galatea Bio, a Miami, FL-based AI-driven genomic research and clinical genetic testing company, raised $25M in funding. Backers included F-Prime, Helios Digital Ventures, Digitalis Ventures, AME Cloud, CEI Ventures, Alexandria, Founders Collective, Stanford President’s Fund, and HBM Genomics. The company intends to use the funds to expand its clinico-genomics platform to integrate multi-modal data and […] The post Galatea Bio Raises $25M in Fund…

6 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year